PTPI Insider Trading Activity and SEC Form 4 Filings
PTPI insider trading summary
No open-market insider purchases or sales of Petros Pharmaceuticals, Inc. (PTPI) have been reported on SEC Form 4 in the past 12 months.
Latest PTPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 22, 2021 | Juggernaut Partners III GP, Ltd. | 10% Owner | Buy | $500K (145,773 @ $3.43) |
| Dec 22, 2021 | Juggernaut Partners III GP, L.P. | 10% Owner | Buy | $500K (145,773 @ $3.43) |
| Dec 22, 2021 | Jcp III Sm Aiv, L.P. | 10% Owner | Buy | $500K (145,773 @ $3.43) |
| Dec 22, 2021 | John D Shulman | Director | Buy | $500K (145,773 @ $3.43) |
| Dec 22, 2021 | METP Holdings LLC | 10% Owner | Buy | $500K (145,773 @ $3.43) |
| Nov 29, 2021 | John D Shulman | Director | Buy | $1.5M (500,000 @ $3.00) |
| Nov 29, 2021 | Jcp III Sm Aiv, L.P. | 10% Owner | Buy | $1.5M (500,000 @ $3.00) |
| Nov 29, 2021 | Juggernaut Partners III GP, L.P. | 10% Owner | Buy | $1.5M (500,000 @ $3.00) |
| Nov 29, 2021 | METP Holdings LLC | 10% Owner | Buy | $1.5M (500,000 @ $3.00) |
| Nov 29, 2021 | Juggernaut Partners III GP, Ltd. | 10% Owner | Buy | $1.5M (500,000 @ $3.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.